My 10-share stock market portfolio for future growth

I have invested in a stock market portfolio of FTSE 350 shares that I expect to continue outperforming these indices over the medium to long term.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Inflation is rampant worldwide. Nevertheless, I believe that — in these difficult times — stock markets still offer the best investment hedge against inflation and excellent long-term return potential for carefully selected shares.

My portfolio

FTSEShareCodeMarket cap (£bn)IndustryYTD % performanceOne-year % performanceThree-year % performance
100AstraZenecaAZN175.8Pharmaceuticals24.1526.5147.23
250BeazleyBEZ3.5Insurance22.1345.240.00
100BunzlBNZL10.6Distribution, logistics-0.358.3342.82
250CapricornCNE0.7Oil, Gas Exploration25.9722.3942.21
100GlencoreGLEN64.9Mining & Trading30.3649.76108.12
250HuntingHTG0.5Energy Industry supplier68.4439.02-37.64
250IndiviorINDV2.1Pharmaceuticals12.0645.31377.45
250MediclinicMDC3.7Health55.5658.1246.85
250SercoSRP2.1Government Services32.1733.5621.93
100SSESSE19.4Power Generation2.512.3046.87
PortfolioAs at 31.8.2227.3033.0569.58

On an equal invested value basis, the portfolio has grown by 69.6% over the past three years (+19.2% per annum). While past performance is no guarantee of future performance, medium to long term I expect the overall portfolio to outperform the FTSE 100 and FTSE 250 indices.

One or two of the stocks may disappoint. Hence, I will actively manage the portfolio and substitute any stocks for which the prospects deteriorate.

AstraZeneca

A British-Swedish multinational pharmaceutical and biotechnology company. It was at the forefront of the rush to develop and distribute a vaccine for Covid-19. Its innovative medicines are used by millions of patients worldwide.

Beazley

A British parent company of worldwide insurance businesses. It underwrites a diverse book of insurance and reinsurance for clients and is a market leader in many of its chosen lines.

Bunzl

A British multinational distribution and outsourcing company. Over 50% of its business is in the food service and food retail sectors.

Capricorn Energy  (previously Cairn Energy)

A British oil and gas exploration and development company. Despite Britain’s net zero objectives, as green billionaire Elon Musk says, “civilization would crumble” if the world stops drilling for oil and gas.

Glencore

An Anglo-Swiss company. One of the world’s largest globally diversified natural resource businesses, being both a mining company and the world’s largest commodities trading firm.

Hunting

A British-based supplier to the oil and gas industry.

Indivior  

A global pharmaceutical company specialising in developing medicines to treat substance use disorders and serious mental illnesses.

Mediclinic International

An international private hospital group with hospitals in South Africa, Namibia, Switzerland and the United Arab Emirates.

Serco

A British contractor for the supply of Government services, primarily in the health, transport, justice, immigration, space, and defense sectors. 55% of the company’s revenue is generated outside the UK.

SSE

Formerly Southern and Scottish Energy, SSE is a multinational energy company that operates UK power stations and offshore wind farms and has a hydroelectric plant in Scotland.

Ian Benfield has positions in AstraZeneca, Beazley, Bunzl, Capricorn Energy, Glencore, Hunting, Indivior, Mediclinic, Serco and SSE. The Motley Fool UK has recommended Bunzl. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Business manager working at a pub doing the accountancy and some paperwork using a laptop computer
Investing Articles

Are investors taking a massive gamble by chasing the BP share price higher?

Investors who thought the BP share price would continue to rocket as the Iran war intensifies may have been surprised…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

Down 23%, consider this FTSE 250 share that’s boosted profit forecasts!

This FTSE 250 tech share's leapt 8% on Wednesday (18 March) after it raised full-year profit forecasts. Is now the…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

4 reasons the Rolls-Royce share price might be headed to £24

Could the Rolls-Royce share price double from around £12 to closer to £24? Here are a few reasons why it…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

How much passive income can you earn by investing £20,000 in a Stocks and Shares ISA?

With dividend yields up to 10%, REITs might be some of the top passive income opportunities for UK investors in…

Read more »

Group of friends meet up in a pub
Investing Articles

Diageo shares are back at 2012 levels. Time to consider buying?

Diageo shares have fallen around 65% from their highs and now trade at levels not seen for well over a…

Read more »

Investing Articles

Softcat: a FTSE 250 tech stock offering growth, dividends and value

Right now, the share price of FTSE 250 IT company Softcat is well off its highs. And at current levels,…

Read more »

Black woman using smartphone at home, watching stock charts.
US Stock

3 huge pieces of news that could impact the Nvidia share price

Jon Smith talks through some key reveals and implications for the Nvidia share price from the company conference taking place…

Read more »

Three signposts pointing in different directions, with 'Buy' 'Sell' and 'Hold' on
Investing For Beginners

This FTSE stock is now trading at the lowest level since the 1990s! Should I buy?

Jon Smith explains why a FTSE share is currently at multi-decade lows and might surprise some with his decision on…

Read more »